Senora 2.5mg Letrozole Tablet – Infertility & Breast Cancer Treatment
Senora 2.5mg Letrozole Tablet is a prescription aromatase inhibitor (AI) with two key uses: ovulation induction in women with infertility and adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women. Reduces oestrogen production by inhibiting CYP19A1 aromatase. Prescription-only oncology and fertility medicine available at Derma.pk.
Pay in 3 Installments of
Rs.
460
Senora 2.5mg Letrozole Tablet – Infertility & Breast Cancer Treatment
Description
Senora 2.5mg is a prescription aromatase inhibitor (AI) containing Letrozole 2.5mg, indicated for two distinct clinical uses: ovulation induction in women with infertility (particularly those with polycystic ovary syndrome or unexplained anovulation) and adjuvant or extended adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women.
As an aromatase inhibitor, Letrozole competitively and reversibly inhibits aromatase (CYP19A1), the enzyme responsible for converting androgens to oestrogens in peripheral tissues. In postmenopausal women, oestrogen deprivation via aromatase inhibition suppresses hormone-sensitive tumour growth and reduces risk of recurrence. In pre- and peri-menopausal women with infertility, low-dose Letrozole stimulates follicular development and ovulation by temporarily reducing oestrogen-mediated negative feedback on the pituitary-ovarian axis.
Senora 2.5mg is taken orally once daily; the duration of therapy differs significantly between oncology (up to 5 years extended adjuvant therapy) and infertility (typically days 2–6 of the menstrual cycle). Bone density monitoring is recommended for long-term oncology use. Letrozole is contraindicated in pregnancy — effective contraception must be used during fertility cycles if not attempting conception that cycle. Common side effects include hot flushes, arthralgia, fatigue, and headache.
Senora 2.5mg is a prescription-required medication. Submit your valid prescription via email: sales@derma.pk or WhatsApp: +92-320-5999650. Nationwide delivery available across Pakistan.
Usage & Benefits
- Potent aromatase inhibition reduces oestrogen to suppress hormone-sensitive breast tumour growth
- Induces ovulation in anovulatory women for infertility treatment
- Reduces risk of breast cancer recurrence when used as extended adjuvant therapy
- Effective in postmenopausal women with HR-positive, HER2-negative breast cancer
- Well-established first-line fertility agent with proven pregnancy rates in PCOS and unexplained infertility
How To Use
Use only as directed by your healthcare provider.
1. For infertility: take 2.5mg once daily on days 2–6 of the menstrual cycle, as prescribed by your gynaecologist or reproductive endocrinologist.
2. For breast cancer: take 2.5mg once daily as prescribed by your oncologist, usually for 5 years.
3. Swallow the tablet whole with a full glass of water at the same time each day.
4. Avoid alcohol and grapefruit during treatment.
5. Attend regular monitoring appointments for bone density, liver function, and cholesterol as advised.
FAQs
What are the two main uses of Senora 2.5mg Letrozole?
Senora 2.5mg is used for (1) ovulation induction in women with infertility (including PCOS and unexplained anovulation) and (2) adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women.
Can Senora be used during pregnancy?
No. Letrozole is contraindicated in pregnancy and breastfeeding due to potential foetal harm. Effective contraception is required during fertility treatment cycles not intended for conception.
Does Senora require a prescription?
Yes. Senora 2.5mg is a prescription-only aromatase inhibitor. Submit your valid prescription to Derma.pk via email: sales@derma.pk or WhatsApp: +92-320-5999650.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
